Get the Stockscreener App
0.6412
8.66%
-0.0608
After Hours:
.65
0.0088
+1.37%
VolitionRX Ltd stock is traded at $0.6412, with a volume of 78,681.
It is down -8.66% in the last 24 hours and down -15.63% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.702
Open:
$0.71
24h Volume:
78,681
Relative Volume:
0.32
Market Cap:
$66.67M
Revenue:
$1.29M
Net Income/Loss:
$-29.87M
P/E Ratio:
-1.7811
EPS:
-0.36
Net Cash Flow:
$-14.70M
1W Performance:
-12.20%
1M Performance:
-15.63%
6M Performance:
+7.76%
1Y Performance:
-3.14%
1-Day Range:
$0.6412
$0.72
1-Week Range:
$0.6412
$0.80
52-Week Range:
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.6412 | 73.00M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
What risks could impact VolitionRx Limited stock performanceFree Reliable Investment Entry Point Signals - Newser
Automated trading signals detected on VolitionRx LimitedFree AI Driven Buy Alert Trade Blueprint - Newser
Applying big data sentiment scoring on VolitionRx LimitedInvestment Timeline and ROI Summary Report - Newser
VolitionRx Limited Rebounds From Oversold Zone — Now WhatSwing Trading Plan With Smart Signals in Review - metal.it
Short Term Charts Align With Long Term Uptrend in VolitionRx LimitedBuy Alerts With Low Risk Confirmation Noted - beatles.ru
What makes VolitionRx Limited stock price move sharplyPost Market Recommendation For 2025 - jammulinksnews.com
When is VolitionRx Limited stock expected to show significant growthAdvanced Screener Data Feed To Watch Now - jammulinksnews.com
What markets is VolitionRx Limited expanding into Is FOXO stock a good long term investment optionMassive stock growth - jammulinksnews.com
What are the latest earnings results for VolitionRx LimitedGet alerts on the hottest market movers - jammulinksnews.com
How many analysts rate VolitionRx Limited as a “Buy”Unlock daily market insights for better trades - jammulinksnews.com
Does VolitionRx Limited stock perform well during market downturnsAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
What is the risk reward ratio of investing in VolitionRx Limited stockAchieve breakthrough investment performance - jammulinksnews.com
Buy Signal for VolitionRx Limited Stock Key Technical Indicators to WatchBig Return Stock Tips - Newser
Why VolitionRx Limited stock attracts strong analyst attentionProtected Capital Trading Plan - metal.it
How VolitionRx Limited stock performs during market volatilityFree Access to Community - Newser
What analysts say about VolitionRx Limited stockFree Stock Selection - PrintWeekIndia
VolitionRx Limited Stock Analysis and ForecastOutstanding capital growth - jammulinksnews.com
What analysts say about BGSF stockUnmatched profit growth - jammulinksnews.com
Is VolitionRx Limited a good long term investmentSky-high profits - jammulinksnews.com
What drives VolitionRx Limited stock pricePowerful profit generation - jammulinksnews.com
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - MarketScreener
VolitionRx Limited Announces Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - MarketScreener
Breakthrough: New 5-Minute Blood Test Could Transform Emergency Care and Sepsis Detection - Stock Titan
Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - Ariva
VolitionRx:Nu.Q advances in lung cancer management - research-tree.com
VNRX INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of VolitionRx Ltd. (NYSE: VNRX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock By Investing.com - Investing.com India
VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock - Investing.com
Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1 Concentrations Are Closely Associated With Sepsis And Organ Failure - MarketScreener
VolitionRx (NYSE:VNRX) Rating Increased to Strong-Buy at Jones Trading - Defense World
VolitionRX (VNRX) Coverage Initiated with a 'Buy' Rating by Jones Trading | VNRX Stock News - GuruFocus
JonesTrading Initiates Coverage on VolitionRx Limited With Buy Rating, $3 Price Target - marketscreener.com
This Yum! Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga
Jones Trading initiates VolitionRX with Buy, sets $3 target By Investing.com - Investing.com India
VolitionRx (VNRX) Receives Buy Rating with Promising Price Targe - GuruFocus
VolitionRx initiated with a Buy at JonesResearch - TipRanks
VolitionRx (VNRX) Receives Buy Rating with Promising Price Target | VNRX Stock News - GuruFocus
Director Makes Bold Move with Major VolitionRX Stock Purchase - TipRanks
Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties - Yahoo Finance
VolitionRx director Guy Innes buys $10,772 in common stock By Investing.com - Investing.com South Africa
VolitionRx director Guy Innes buys $10,772 in common stock - Investing.com
VNRX: Management's key financial goal for 2025 is to be cash neutral on a full year basis. - Research Tree
VNRX: Management’s key financial goal for 2025 is to be cash neutral on a full year basis. Four operational milestones have been achieved thus far in 2025. Primary operational goal is to enter into multiple licensing agreements for human diagnostic applicati - Yahoo Finance
VolitionRx Limited (AMEX:VNRX) Q1 2025 Earnings Call Transcript - Insider Monkey
VolitionRX Ltd. Earnings Call Reveals Promising Growth - TipRanks
VolitionRX shares hold as Benchmark maintains rating - Investing.com Australia
VNRX stock touches 52-week low at $0.42 amid market challenges - Investing.com Canada
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):